
Medically Reviewed By
Dr. Neha Gupta ( Medical Oncology)
A crucial clinical daycare oncology guide on Totally Implantable Venous Access Devices (TIVAD / Chemoports), detailing ultrasound-guided right internal jugular vein cannulation, C-arm tip positioning at the cavoatrial junction, preventing catheter-related thrombosis, and painless Huber needle access.
CRITICAL CLINICAL RED FLAG: Any severe burning sensation, swelling, or redness at a peripheral IV chemotherapy site indicates drug extravasation (tissue necrosis risk) and demands immediate cessation of infusion and cold/warm compress intervention.
Vesicant and irritant chemotherapeutic agents (Doxorubicin, Cisplatin, Paclitaxel, Vinorelbine) cause severe chemical phlebitis, thrombosis, and irreversible sclerosis of delicate arm veins over multiple cycles. A Totally Implantable Venous Access Device (Chemoport) provides secure, painless central venous access.
Central Dilution: High-volume blood flow in the superior vena cava (>2 L/min) instantly dilutes concentrated chemotherapy drugs, preventing venous irritation.
Under-the-Skin Reservoir: The port sits completely under the skin below the collarbone, allowing patients to shower, swim, and perform normal daily routines without external bandages.
Performed under local anesthesia with light sedation in a minor surgical suite in under 20 minutes:
Real-Time Micro-Ultrasound: Cannulation of the right Internal Jugular Vein (IJV) with zero risk of pneumothorax.
Subcutaneous Tunneling: Silastic catheter tunneled over the pectoral fascia to a small 2.5 cm subclavicular pocket.
C-Arm Fluoroscopic Verification: The catheter tip is positioned precisely at the Cavoatrial Junction (CAJ) to avoid arrhythmia or turbulent clotting.
"A chemoport completely transforms the cancer treatment journey: it eliminates repeated painful vein pricks, protects your peripheral veins from corrosive chemotherapy, and allows full freedom of movement." — Dr. Neha Gupta

The port's self-sealing silicone septum withstands up to 2,000 punctures. Special non-coring Huber needles and topical lidocaine/prilocaine cream provide 100% painless needle insertion.
CLINICAL CAUTION: Blind anatomical landmark cannulation of the subclavian vein carries a high risk of pneumothorax, arterial puncture, and catheter pinch-off syndrome; real-time ultrasound guidance is mandatory.
Flushing with 10 mL normal saline followed by a 100 U/mL heparin lock after every chemotherapy infusion or every 4 to 6 weeks during remission keeps the port patent and functional for 5+ years.
1. Clinical Practice Guidelines for Central Venous Access in Oncology Patients — Annals of Oncology, 2021; 32(5): 580-595.
2. Complication rates of ultrasound-guided internal jugular chemoport placement in 1,200 cancer patients — J Surg Oncol, 2022; 125(3): 450-458.

Senior Consultant & Clinical Director — Medical Oncology
MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi

13+ Years Experience
Spica — Grover Hospital
Request a priority OPD appointment or second opinion on your scans.
Proprietary surgical methodologies and precision protocols pioneered by our senior directors to minimize trauma, protect natural anatomy, and accelerate recovery.

Dr. Deepak Garg (Orthopaedic Surgical Oncology - RGCI Delhi Trained) and Dr. Neha Gupta (Medical Oncology) co-lead the Bone Cancer & Sarcoma Center at Spica Healthcare. Integrating intensive multi-agent neoadjuvant chemotherapy protocols (MAP: High-Dose Methotrexate, Doxorubicin, Cisplatin for Osteosarcoma; VIDE: Vincristine, Ifosfamide, Doxorubicin, Etoposide for Ewing Sarcoma) with 3D computer-navigated limb salvage surgery and modular titanium megaprosthetic joint reconstruction, 5-year survival rates exceed 75% to 80% while saving over 95% of patients from limb amputation.
Spica Healthcare — Bone and Cancer Institute, Bathinda — is South-Western Punjab's premier super-speciality centre led by AIIMS and Tata Memorial fellowship-trained directors.
Every diagnostic MRI review, surgical staging, and operation is personally directed by chief clinical specialists — Dr. Deepak Garg (Orthopaedic Oncology & Robotics) and Dr. Neha Gupta (Medical Oncology) — guaranteeing zero junior proxies.
Sub-millimeter implant positioning and soft-tissue ligament balancing ensuring patients walk comfortably within 24 hours of total knee replacement.
South-West Punjab's only dedicated centre for modular titanium megaprosthesis, saving natural limbs and functions in 95%+ of bone cancer patients.
Full cashless coverage for Ayushman Bharat (PM-JAY), Punjab Govt Health Schemes, ECHS, and 30+ private insurance networks with on-desk approvals.
Positive-pressure HEPA filtered theatres minimizing infection rates below international benchmarks with 24/7 dedicated critical care backup.
Fellowship-trained surgical directors from AIIMS & Tata Memorial providing compassionate, world-class tertiary care in super-speciality orthopaedics and medical oncology.

Senior Consultant & Clinical Director — Medical Oncology
MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi


Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery
16+ Yrs ExpSenior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery
MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)
Free OPD screening camps, director-led masterclasses, and national oncology representations by Spica Healthcare.
Real stories from patients who recovered through limb preservation surgery, 3D robotic joint replacements, and precision cancer care at Spica Healthcare — Grover Hospital, Bathinda.
Evidence-based surgical recovery roadmaps, robotic joint protocols, and precision oncology insights written by our clinical directors.